Novo Nordisk A/S (NYSE:NVO)

55.18
Delayed Data
As of Jul 02
 -0.26 / -0.47%
Today’s Change
41.72
Today|||52-Week Range
58.21
+30.39%
Year-to-Date

Today’s Trading

Previous close55.44
Today’s open54.92
Day’s range54.86 - 55.45
Volume925,959
Average volume (3 months)1,322,308
Market cap$110.7B
Dividend yield1.38%
Data as of 4:04pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.60%
Revenue growth (last year)+5.60%
P/E ratio4.8
Price/Sales7.07
Price/Book21.85

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.19-0.28%
ABBVAbbVie-0.30-0.44%
GSKGlaxoSmithKline+0.12+0.28%
LLYEli Lilly and Co+1.29+1.52%
Data as of 4:04pm ET, 07/02/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.47
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers